glp-1 obesity drug news today oct 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Weight Loss Drug Market
Description
Wegovy is not a new drug
Whilst there is consensus appreciation of the reduction in perioperative cardiometabolic complications these agents provide in improving glycaemic control, it would be remiss to discount the unquantified risk of aspiration from GLP-1 agonists during airway management
Biopolymers 22 , 25772637 (1983)
Clinical vigilance is advised, particularly for symptoms such as a neck mass, dysphagia, or persistent hoarseness
This method not only saves time by reducing the number of items that must be decontaminated or brought into the cleanroom, but also improves surface coverage, lowering the risk of missed spots or insufficient wetting during residue removal
Steven Klein, a physician at the nonprofit Caron Treatment Centers in Providence
